nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—CYP2B6—Thiotepa—sarcoma	0.241	0.29	CbGbCtD
Enzalutamide—CYP3A4—Thiotepa—sarcoma	0.0739	0.0891	CbGbCtD
Enzalutamide—ABCB1—Dactinomycin—sarcoma	0.0593	0.0714	CbGbCtD
Enzalutamide—CYP3A5—Vincristine—sarcoma	0.0561	0.0676	CbGbCtD
Enzalutamide—ABCB1—Mitoxantrone—sarcoma	0.053	0.0639	CbGbCtD
Enzalutamide—CYP3A5—Etoposide—sarcoma	0.0514	0.0619	CbGbCtD
Enzalutamide—CYP2C8—Etoposide—sarcoma	0.0494	0.0595	CbGbCtD
Enzalutamide—CYP2B6—Doxorubicin—sarcoma	0.0445	0.0536	CbGbCtD
Enzalutamide—ABCB1—Vincristine—sarcoma	0.0365	0.044	CbGbCtD
Enzalutamide—ABCB1—Etoposide—sarcoma	0.0334	0.0403	CbGbCtD
Enzalutamide—CYP3A4—Mitoxantrone—sarcoma	0.0318	0.0383	CbGbCtD
Enzalutamide—ABCB1—Doxorubicin—sarcoma	0.0228	0.0275	CbGbCtD
Enzalutamide—CYP3A4—Vincristine—sarcoma	0.0219	0.0264	CbGbCtD
Enzalutamide—CYP2D6—Doxorubicin—sarcoma	0.0215	0.0259	CbGbCtD
Enzalutamide—CYP3A4—Etoposide—sarcoma	0.02	0.0241	CbGbCtD
Enzalutamide—CYP3A4—Doxorubicin—sarcoma	0.0137	0.0165	CbGbCtD
Enzalutamide—AR—scrotum—sarcoma	0.00904	0.283	CbGeAlD
Enzalutamide—Cognitive disorder—Thiotepa—sarcoma	0.00488	0.0353	CcSEcCtD
Enzalutamide—Memory impairment—Thiotepa—sarcoma	0.00269	0.0195	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Vincristine—sarcoma	0.0019	0.0137	CcSEcCtD
Enzalutamide—Sepsis—Thiotepa—sarcoma	0.00183	0.0133	CcSEcCtD
Enzalutamide—Sepsis—Dactinomycin—sarcoma	0.00182	0.0132	CcSEcCtD
Enzalutamide—Sepsis—Mitoxantrone—sarcoma	0.00158	0.0115	CcSEcCtD
Enzalutamide—ALB—mammary gland—sarcoma	0.00148	0.0463	CbGeAlD
Enzalutamide—Sepsis—Etoposide—sarcoma	0.00132	0.00953	CcSEcCtD
Enzalutamide—Neutropenia—Dactinomycin—sarcoma	0.00123	0.0089	CcSEcCtD
Enzalutamide—Muscular weakness—Vincristine—sarcoma	0.0012	0.00868	CcSEcCtD
Enzalutamide—Pneumonia—Thiotepa—sarcoma	0.00119	0.0086	CcSEcCtD
Enzalutamide—Infestation NOS—Thiotepa—sarcoma	0.00118	0.00855	CcSEcCtD
Enzalutamide—Infestation—Thiotepa—sarcoma	0.00118	0.00855	CcSEcCtD
Enzalutamide—Laryngitis—Epirubicin—sarcoma	0.00118	0.00854	CcSEcCtD
Enzalutamide—Pneumonia—Dactinomycin—sarcoma	0.00118	0.00853	CcSEcCtD
Enzalutamide—Haematuria—Thiotepa—sarcoma	0.00113	0.00815	CcSEcCtD
Enzalutamide—Epistaxis—Thiotepa—sarcoma	0.00111	0.00806	CcSEcCtD
Enzalutamide—Neutropenia—Vincristine—sarcoma	0.0011	0.00795	CcSEcCtD
Enzalutamide—Laryngitis—Doxorubicin—sarcoma	0.00109	0.0079	CcSEcCtD
Enzalutamide—Neutropenia—Mitoxantrone—sarcoma	0.00107	0.00774	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00106	0.0077	CcSEcCtD
Enzalutamide—Pneumonia—Vincristine—sarcoma	0.00105	0.00762	CcSEcCtD
Enzalutamide—Urinary tract disorder—Thiotepa—sarcoma	0.00105	0.00758	CcSEcCtD
Enzalutamide—Pharyngitis—Dactinomycin—sarcoma	0.00104	0.00756	CcSEcCtD
Enzalutamide—Connective tissue disorder—Thiotepa—sarcoma	0.00104	0.00754	CcSEcCtD
Enzalutamide—CYP2C8—mammary gland—sarcoma	0.00104	0.0325	CbGeAlD
Enzalutamide—Urethral disorder—Thiotepa—sarcoma	0.00104	0.00752	CcSEcCtD
Enzalutamide—Pneumonia—Mitoxantrone—sarcoma	0.00103	0.00743	CcSEcCtD
Enzalutamide—Haematuria—Mitoxantrone—sarcoma	0.000973	0.00704	CcSEcCtD
Enzalutamide—Angiopathy—Thiotepa—sarcoma	0.000962	0.00696	CcSEcCtD
Enzalutamide—Sinusitis—Mitoxantrone—sarcoma	0.000957	0.00693	CcSEcCtD
Enzalutamide—Hypoaesthesia—Vincristine—sarcoma	0.000936	0.00677	CcSEcCtD
Enzalutamide—Mental disorder—Thiotepa—sarcoma	0.000929	0.00672	CcSEcCtD
Enzalutamide—Urinary tract disorder—Vincristine—sarcoma	0.000929	0.00672	CcSEcCtD
Enzalutamide—Connective tissue disorder—Vincristine—sarcoma	0.000924	0.00669	CcSEcCtD
Enzalutamide—CYP2C9—mammary gland—sarcoma	0.000923	0.0289	CbGeAlD
Enzalutamide—Urethral disorder—Vincristine—sarcoma	0.000922	0.00667	CcSEcCtD
Enzalutamide—Rhinitis—Mitoxantrone—sarcoma	0.000918	0.00664	CcSEcCtD
Enzalutamide—AR—myometrium—sarcoma	0.000912	0.0285	CbGeAlD
Enzalutamide—Pharyngitis—Mitoxantrone—sarcoma	0.000909	0.00658	CcSEcCtD
Enzalutamide—Back pain—Thiotepa—sarcoma	0.000893	0.00646	CcSEcCtD
Enzalutamide—Neutropenia—Etoposide—sarcoma	0.00089	0.00644	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Epirubicin—sarcoma	0.000861	0.00623	CcSEcCtD
Enzalutamide—Pneumonia—Etoposide—sarcoma	0.000853	0.00618	CcSEcCtD
Enzalutamide—Angiopathy—Vincristine—sarcoma	0.000853	0.00617	CcSEcCtD
Enzalutamide—Infestation NOS—Etoposide—sarcoma	0.000848	0.00614	CcSEcCtD
Enzalutamide—Infestation—Etoposide—sarcoma	0.000848	0.00614	CcSEcCtD
Enzalutamide—Leukopenia—Thiotepa—sarcoma	0.000826	0.00598	CcSEcCtD
Enzalutamide—AR—seminal vesicle—sarcoma	0.000824	0.0258	CbGeAlD
Enzalutamide—Mental disorder—Vincristine—sarcoma	0.000824	0.00596	CcSEcCtD
Enzalutamide—Leukopenia—Dactinomycin—sarcoma	0.00082	0.00594	CcSEcCtD
Enzalutamide—Convulsion—Thiotepa—sarcoma	0.0008	0.00579	CcSEcCtD
Enzalutamide—Hypertension—Thiotepa—sarcoma	0.000797	0.00577	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Doxorubicin—sarcoma	0.000796	0.00576	CcSEcCtD
Enzalutamide—Back pain—Vincristine—sarcoma	0.000792	0.00573	CcSEcCtD
Enzalutamide—Arthralgia—Thiotepa—sarcoma	0.000786	0.00569	CcSEcCtD
Enzalutamide—Anxiety—Thiotepa—sarcoma	0.000783	0.00567	CcSEcCtD
Enzalutamide—AR—hematopoietic system—sarcoma	0.000783	0.0245	CbGeAlD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00078	0.00565	CcSEcCtD
Enzalutamide—Back pain—Mitoxantrone—sarcoma	0.000771	0.00558	CcSEcCtD
Enzalutamide—Hypoaesthesia—Etoposide—sarcoma	0.000758	0.00549	CcSEcCtD
Enzalutamide—AR—connective tissue—sarcoma	0.000754	0.0236	CbGeAlD
Enzalutamide—Urinary tract disorder—Etoposide—sarcoma	0.000752	0.00544	CcSEcCtD
Enzalutamide—Infection—Thiotepa—sarcoma	0.000748	0.00542	CcSEcCtD
Enzalutamide—Urethral disorder—Etoposide—sarcoma	0.000747	0.0054	CcSEcCtD
Enzalutamide—Infection—Dactinomycin—sarcoma	0.000743	0.00538	CcSEcCtD
Enzalutamide—Nervous system disorder—Thiotepa—sarcoma	0.000739	0.00535	CcSEcCtD
Enzalutamide—Sepsis—Epirubicin—sarcoma	0.000738	0.00534	CcSEcCtD
Enzalutamide—Thrombocytopenia—Thiotepa—sarcoma	0.000738	0.00534	CcSEcCtD
Enzalutamide—Vertigo—Vincristine—sarcoma	0.000735	0.00532	CcSEcCtD
Enzalutamide—Leukopenia—Vincristine—sarcoma	0.000733	0.0053	CcSEcCtD
Enzalutamide—Thrombocytopenia—Dactinomycin—sarcoma	0.000732	0.0053	CcSEcCtD
Enzalutamide—Skin disorder—Thiotepa—sarcoma	0.000732	0.0053	CcSEcCtD
Enzalutamide—CYP2C19—hematopoietic system—sarcoma	0.000726	0.0227	CbGeAlD
Enzalutamide—Leukopenia—Mitoxantrone—sarcoma	0.000714	0.00516	CcSEcCtD
Enzalutamide—Convulsion—Vincristine—sarcoma	0.000709	0.00513	CcSEcCtD
Enzalutamide—Hypertension—Vincristine—sarcoma	0.000707	0.00511	CcSEcCtD
Enzalutamide—Angiopathy—Etoposide—sarcoma	0.000691	0.005	CcSEcCtD
Enzalutamide—Convulsion—Mitoxantrone—sarcoma	0.000691	0.005	CcSEcCtD
Enzalutamide—AR—smooth muscle tissue—sarcoma	0.00069	0.0216	CbGeAlD
Enzalutamide—Hypertension—Mitoxantrone—sarcoma	0.000688	0.00498	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000686	0.00497	CcSEcCtD
Enzalutamide—Sepsis—Doxorubicin—sarcoma	0.000683	0.00494	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000681	0.00493	CcSEcCtD
Enzalutamide—AR—skin of body—sarcoma	0.000681	0.0213	CbGeAlD
Enzalutamide—Arthralgia—Mitoxantrone—sarcoma	0.000679	0.00491	CcSEcCtD
Enzalutamide—Paraesthesia—Thiotepa—sarcoma	0.000676	0.0049	CcSEcCtD
Enzalutamide—Anxiety—Mitoxantrone—sarcoma	0.000676	0.00489	CcSEcCtD
Enzalutamide—Infection—Vincristine—sarcoma	0.000664	0.0048	CcSEcCtD
Enzalutamide—Hot flush—Epirubicin—sarcoma	0.00066	0.00478	CcSEcCtD
Enzalutamide—Nervous system disorder—Vincristine—sarcoma	0.000655	0.00474	CcSEcCtD
Enzalutamide—Menopausal symptoms—Epirubicin—sarcoma	0.000654	0.00473	CcSEcCtD
Enzalutamide—Thrombocytopenia—Vincristine—sarcoma	0.000654	0.00473	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Thiotepa—sarcoma	0.00065	0.00471	CcSEcCtD
Enzalutamide—Fatigue—Thiotepa—sarcoma	0.00065	0.0047	CcSEcCtD
Enzalutamide—Infection—Mitoxantrone—sarcoma	0.000646	0.00468	CcSEcCtD
Enzalutamide—Fatigue—Dactinomycin—sarcoma	0.000645	0.00467	CcSEcCtD
Enzalutamide—Back pain—Etoposide—sarcoma	0.000641	0.00464	CcSEcCtD
Enzalutamide—Thrombocytopenia—Mitoxantrone—sarcoma	0.000637	0.00461	CcSEcCtD
Enzalutamide—CYP2C8—hematopoietic system—sarcoma	0.000633	0.0198	CbGeAlD
Enzalutamide—Skin disorder—Mitoxantrone—sarcoma	0.000632	0.00457	CcSEcCtD
Enzalutamide—Hot flush—Doxorubicin—sarcoma	0.00061	0.00442	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Vincristine—sarcoma	0.000609	0.0044	CcSEcCtD
Enzalutamide—Menopausal symptoms—Doxorubicin—sarcoma	0.000605	0.00438	CcSEcCtD
Enzalutamide—Insomnia—Vincristine—sarcoma	0.000604	0.00437	CcSEcCtD
Enzalutamide—Paraesthesia—Vincristine—sarcoma	0.0006	0.00434	CcSEcCtD
Enzalutamide—Vertigo—Etoposide—sarcoma	0.000596	0.00431	CcSEcCtD
Enzalutamide—AR—cardiac atrium—sarcoma	0.000595	0.0186	CbGeAlD
Enzalutamide—Leukopenia—Etoposide—sarcoma	0.000594	0.0043	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000593	0.00429	CcSEcCtD
Enzalutamide—AR—uterus—sarcoma	0.000592	0.0185	CbGeAlD
Enzalutamide—Paraesthesia—Mitoxantrone—sarcoma	0.000584	0.00423	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Vincristine—sarcoma	0.000577	0.00417	CcSEcCtD
Enzalutamide—Fatigue—Vincristine—sarcoma	0.000576	0.00417	CcSEcCtD
Enzalutamide—Convulsion—Etoposide—sarcoma	0.000574	0.00416	CcSEcCtD
Enzalutamide—Hypertension—Etoposide—sarcoma	0.000572	0.00414	CcSEcCtD
Enzalutamide—CYP3A5—hematopoietic system—sarcoma	0.000572	0.0179	CbGeAlD
Enzalutamide—CYP2B6—hematopoietic system—sarcoma	0.000568	0.0178	CbGeAlD
Enzalutamide—Dry skin—Epirubicin—sarcoma	0.000566	0.00409	CcSEcCtD
Enzalutamide—CYP2C9—hematopoietic system—sarcoma	0.000563	0.0176	CbGeAlD
Enzalutamide—Fatigue—Mitoxantrone—sarcoma	0.000561	0.00406	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000561	0.00406	CcSEcCtD
Enzalutamide—Nasopharyngitis—Epirubicin—sarcoma	0.000552	0.00399	CcSEcCtD
Enzalutamide—AR—lymphoid tissue—sarcoma	0.000551	0.0172	CbGeAlD
Enzalutamide—Muscular weakness—Epirubicin—sarcoma	0.000544	0.00394	CcSEcCtD
Enzalutamide—Asthenia—Thiotepa—sarcoma	0.000541	0.00391	CcSEcCtD
Enzalutamide—Infection—Etoposide—sarcoma	0.000538	0.00389	CcSEcCtD
Enzalutamide—Asthenia—Dactinomycin—sarcoma	0.000536	0.00388	CcSEcCtD
Enzalutamide—Pruritus—Thiotepa—sarcoma	0.000533	0.00386	CcSEcCtD
Enzalutamide—Thrombocytopenia—Etoposide—sarcoma	0.00053	0.00383	CcSEcCtD
Enzalutamide—Skin disorder—Etoposide—sarcoma	0.000526	0.0038	CcSEcCtD
Enzalutamide—Dry skin—Doxorubicin—sarcoma	0.000523	0.00379	CcSEcCtD
Enzalutamide—AR—tendon—sarcoma	0.000518	0.0162	CbGeAlD
Enzalutamide—Diarrhoea—Thiotepa—sarcoma	0.000515	0.00373	CcSEcCtD
Enzalutamide—Bronchitis—Epirubicin—sarcoma	0.000513	0.00371	CcSEcCtD
Enzalutamide—Diarrhoea—Dactinomycin—sarcoma	0.000512	0.0037	CcSEcCtD
Enzalutamide—Nasopharyngitis—Doxorubicin—sarcoma	0.000511	0.0037	CcSEcCtD
Enzalutamide—Muscular weakness—Doxorubicin—sarcoma	0.000504	0.00365	CcSEcCtD
Enzalutamide—Neutropenia—Epirubicin—sarcoma	0.000499	0.00361	CcSEcCtD
Enzalutamide—Dizziness—Thiotepa—sarcoma	0.000498	0.00361	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Epirubicin—sarcoma	0.000496	0.00359	CcSEcCtD
Enzalutamide—CYP2B6—skin of body—sarcoma	0.000494	0.0155	CbGeAlD
Enzalutamide—ALB—testis—sarcoma	0.000494	0.0154	CbGeAlD
Enzalutamide—Pollakiuria—Epirubicin—sarcoma	0.000493	0.00357	CcSEcCtD
Enzalutamide—Paraesthesia—Etoposide—sarcoma	0.000486	0.00352	CcSEcCtD
Enzalutamide—Asthenia—Vincristine—sarcoma	0.000479	0.00347	CcSEcCtD
Enzalutamide—Pneumonia—Epirubicin—sarcoma	0.000478	0.00346	CcSEcCtD
Enzalutamide—Infestation NOS—Epirubicin—sarcoma	0.000476	0.00344	CcSEcCtD
Enzalutamide—Infestation—Epirubicin—sarcoma	0.000476	0.00344	CcSEcCtD
Enzalutamide—Bronchitis—Doxorubicin—sarcoma	0.000475	0.00344	CcSEcCtD
Enzalutamide—Headache—Thiotepa—sarcoma	0.000472	0.00342	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Etoposide—sarcoma	0.000467	0.00338	CcSEcCtD
Enzalutamide—ALB—liver—sarcoma	0.000467	0.0146	CbGeAlD
Enzalutamide—Asthenia—Mitoxantrone—sarcoma	0.000467	0.00338	CcSEcCtD
Enzalutamide—Fatigue—Etoposide—sarcoma	0.000467	0.00338	CcSEcCtD
Enzalutamide—Neutropenia—Doxorubicin—sarcoma	0.000462	0.00334	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000459	0.00332	CcSEcCtD
Enzalutamide—Diarrhoea—Vincristine—sarcoma	0.000457	0.00331	CcSEcCtD
Enzalutamide—Pollakiuria—Doxorubicin—sarcoma	0.000456	0.0033	CcSEcCtD
Enzalutamide—Haematuria—Epirubicin—sarcoma	0.000453	0.00328	CcSEcCtD
Enzalutamide—Epistaxis—Epirubicin—sarcoma	0.000449	0.00325	CcSEcCtD
Enzalutamide—Sinusitis—Epirubicin—sarcoma	0.000446	0.00323	CcSEcCtD
Enzalutamide—Diarrhoea—Mitoxantrone—sarcoma	0.000445	0.00322	CcSEcCtD
Enzalutamide—Pneumonia—Doxorubicin—sarcoma	0.000443	0.0032	CcSEcCtD
Enzalutamide—Dizziness—Vincristine—sarcoma	0.000442	0.0032	CcSEcCtD
Enzalutamide—Infestation—Doxorubicin—sarcoma	0.00044	0.00319	CcSEcCtD
Enzalutamide—Infestation NOS—Doxorubicin—sarcoma	0.00044	0.00319	CcSEcCtD
Enzalutamide—AR—testis—sarcoma	0.000429	0.0134	CbGeAlD
Enzalutamide—CYP3A4—hematopoietic system—sarcoma	0.000429	0.0134	CbGeAlD
Enzalutamide—Rhinitis—Epirubicin—sarcoma	0.000428	0.0031	CcSEcCtD
Enzalutamide—Hypoaesthesia—Epirubicin—sarcoma	0.000425	0.00307	CcSEcCtD
Enzalutamide—Pharyngitis—Epirubicin—sarcoma	0.000424	0.00307	CcSEcCtD
Enzalutamide—CYP2D6—hematopoietic system—sarcoma	0.000422	0.0132	CbGeAlD
Enzalutamide—Urinary tract disorder—Epirubicin—sarcoma	0.000422	0.00305	CcSEcCtD
Enzalutamide—Oedema peripheral—Epirubicin—sarcoma	0.000421	0.00304	CcSEcCtD
Enzalutamide—Haematuria—Doxorubicin—sarcoma	0.00042	0.00304	CcSEcCtD
Enzalutamide—Connective tissue disorder—Epirubicin—sarcoma	0.00042	0.00304	CcSEcCtD
Enzalutamide—Urethral disorder—Epirubicin—sarcoma	0.000419	0.00303	CcSEcCtD
Enzalutamide—Headache—Vincristine—sarcoma	0.000419	0.00303	CcSEcCtD
Enzalutamide—Epistaxis—Doxorubicin—sarcoma	0.000415	0.003	CcSEcCtD
Enzalutamide—Sinusitis—Doxorubicin—sarcoma	0.000413	0.00299	CcSEcCtD
Enzalutamide—Headache—Mitoxantrone—sarcoma	0.000408	0.00295	CcSEcCtD
Enzalutamide—AR—liver—sarcoma	0.000406	0.0127	CbGeAlD
Enzalutamide—CYP2B6—lymphoid tissue—sarcoma	0.0004	0.0125	CbGeAlD
Enzalutamide—Rhinitis—Doxorubicin—sarcoma	0.000396	0.00287	CcSEcCtD
Enzalutamide—Hypoaesthesia—Doxorubicin—sarcoma	0.000393	0.00284	CcSEcCtD
Enzalutamide—Pharyngitis—Doxorubicin—sarcoma	0.000392	0.00284	CcSEcCtD
Enzalutamide—Urinary tract disorder—Doxorubicin—sarcoma	0.00039	0.00282	CcSEcCtD
Enzalutamide—Oedema peripheral—Doxorubicin—sarcoma	0.000389	0.00282	CcSEcCtD
Enzalutamide—Asthenia—Etoposide—sarcoma	0.000388	0.00281	CcSEcCtD
Enzalutamide—Connective tissue disorder—Doxorubicin—sarcoma	0.000388	0.00281	CcSEcCtD
Enzalutamide—Angiopathy—Epirubicin—sarcoma	0.000387	0.0028	CcSEcCtD
Enzalutamide—Urethral disorder—Doxorubicin—sarcoma	0.000387	0.0028	CcSEcCtD
Enzalutamide—Pruritus—Etoposide—sarcoma	0.000383	0.00277	CcSEcCtD
Enzalutamide—CYP2C19—liver—sarcoma	0.000376	0.0118	CbGeAlD
Enzalutamide—Mental disorder—Epirubicin—sarcoma	0.000374	0.00271	CcSEcCtD
Enzalutamide—Diarrhoea—Etoposide—sarcoma	0.00037	0.00268	CcSEcCtD
Enzalutamide—Back pain—Epirubicin—sarcoma	0.00036	0.0026	CcSEcCtD
Enzalutamide—Angiopathy—Doxorubicin—sarcoma	0.000358	0.00259	CcSEcCtD
Enzalutamide—ALB—lymph node—sarcoma	0.000358	0.0112	CbGeAlD
Enzalutamide—Dizziness—Etoposide—sarcoma	0.000358	0.00259	CcSEcCtD
Enzalutamide—ABCB1—myometrium—sarcoma	0.000354	0.0111	CbGeAlD
Enzalutamide—CYP2C8—testis—sarcoma	0.000347	0.0109	CbGeAlD
Enzalutamide—Mental disorder—Doxorubicin—sarcoma	0.000346	0.0025	CcSEcCtD
Enzalutamide—ABCB1—embryo—sarcoma	0.00034	0.0106	CbGeAlD
Enzalutamide—Headache—Etoposide—sarcoma	0.000339	0.00245	CcSEcCtD
Enzalutamide—Vertigo—Epirubicin—sarcoma	0.000334	0.00242	CcSEcCtD
Enzalutamide—Leukopenia—Epirubicin—sarcoma	0.000333	0.00241	CcSEcCtD
Enzalutamide—Back pain—Doxorubicin—sarcoma	0.000333	0.00241	CcSEcCtD
Enzalutamide—CYP2C8—liver—sarcoma	0.000328	0.0103	CbGeAlD
Enzalutamide—Convulsion—Epirubicin—sarcoma	0.000322	0.00233	CcSEcCtD
Enzalutamide—Hypertension—Epirubicin—sarcoma	0.000321	0.00232	CcSEcCtD
Enzalutamide—ABCB1—seminal vesicle—sarcoma	0.000319	0.00999	CbGeAlD
Enzalutamide—Arthralgia—Epirubicin—sarcoma	0.000316	0.00229	CcSEcCtD
Enzalutamide—Anxiety—Epirubicin—sarcoma	0.000315	0.00228	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000314	0.00227	CcSEcCtD
Enzalutamide—CYP2B6—testis—sarcoma	0.000311	0.00974	CbGeAlD
Enzalutamide—AR—lymph node—sarcoma	0.000311	0.00973	CbGeAlD
Enzalutamide—Vertigo—Doxorubicin—sarcoma	0.000309	0.00224	CcSEcCtD
Enzalutamide—Leukopenia—Doxorubicin—sarcoma	0.000308	0.00223	CcSEcCtD
Enzalutamide—ABCB1—hematopoietic system—sarcoma	0.000304	0.0095	CbGeAlD
Enzalutamide—Infection—Epirubicin—sarcoma	0.000301	0.00218	CcSEcCtD
Enzalutamide—Convulsion—Doxorubicin—sarcoma	0.000298	0.00216	CcSEcCtD
Enzalutamide—Nervous system disorder—Epirubicin—sarcoma	0.000297	0.00215	CcSEcCtD
Enzalutamide—Thrombocytopenia—Epirubicin—sarcoma	0.000297	0.00215	CcSEcCtD
Enzalutamide—Hypertension—Doxorubicin—sarcoma	0.000297	0.00215	CcSEcCtD
Enzalutamide—CYP3A5—liver—sarcoma	0.000296	0.00926	CbGeAlD
Enzalutamide—Skin disorder—Epirubicin—sarcoma	0.000295	0.00213	CcSEcCtD
Enzalutamide—CYP2B6—liver—sarcoma	0.000294	0.00921	CbGeAlD
Enzalutamide—Arthralgia—Doxorubicin—sarcoma	0.000293	0.00212	CcSEcCtD
Enzalutamide—Anxiety—Doxorubicin—sarcoma	0.000292	0.00211	CcSEcCtD
Enzalutamide—CYP2C9—liver—sarcoma	0.000291	0.00912	CbGeAlD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000291	0.0021	CcSEcCtD
Enzalutamide—Infection—Doxorubicin—sarcoma	0.000279	0.00202	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000276	0.002	CcSEcCtD
Enzalutamide—Nervous system disorder—Doxorubicin—sarcoma	0.000275	0.00199	CcSEcCtD
Enzalutamide—Thrombocytopenia—Doxorubicin—sarcoma	0.000275	0.00199	CcSEcCtD
Enzalutamide—Insomnia—Epirubicin—sarcoma	0.000274	0.00199	CcSEcCtD
Enzalutamide—Skin disorder—Doxorubicin—sarcoma	0.000273	0.00197	CcSEcCtD
Enzalutamide—Paraesthesia—Epirubicin—sarcoma	0.000272	0.00197	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000262	0.0019	CcSEcCtD
Enzalutamide—Fatigue—Epirubicin—sarcoma	0.000262	0.00189	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000256	0.00185	CcSEcCtD
Enzalutamide—Insomnia—Doxorubicin—sarcoma	0.000254	0.00184	CcSEcCtD
Enzalutamide—Paraesthesia—Doxorubicin—sarcoma	0.000252	0.00182	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000242	0.00175	CcSEcCtD
Enzalutamide—Fatigue—Doxorubicin—sarcoma	0.000242	0.00175	CcSEcCtD
Enzalutamide—CYP2D6—testis—sarcoma	0.000231	0.00724	CbGeAlD
Enzalutamide—ABCB1—uterus—sarcoma	0.000229	0.00718	CbGeAlD
Enzalutamide—CYP3A4—liver—sarcoma	0.000222	0.00695	CbGeAlD
Enzalutamide—CYP2D6—liver—sarcoma	0.000219	0.00684	CbGeAlD
Enzalutamide—Asthenia—Epirubicin—sarcoma	0.000218	0.00158	CcSEcCtD
Enzalutamide—Pruritus—Epirubicin—sarcoma	0.000215	0.00155	CcSEcCtD
Enzalutamide—ABCB1—lymphoid tissue—sarcoma	0.000214	0.00669	CbGeAlD
Enzalutamide—Diarrhoea—Epirubicin—sarcoma	0.000208	0.0015	CcSEcCtD
Enzalutamide—Asthenia—Doxorubicin—sarcoma	0.000201	0.00146	CcSEcCtD
Enzalutamide—Dizziness—Epirubicin—sarcoma	0.000201	0.00145	CcSEcCtD
Enzalutamide—Pruritus—Doxorubicin—sarcoma	0.000199	0.00144	CcSEcCtD
Enzalutamide—ABCB1—bone marrow—sarcoma	0.000195	0.00609	CbGeAlD
Enzalutamide—Diarrhoea—Doxorubicin—sarcoma	0.000192	0.00139	CcSEcCtD
Enzalutamide—Headache—Epirubicin—sarcoma	0.00019	0.00138	CcSEcCtD
Enzalutamide—Dizziness—Doxorubicin—sarcoma	0.000186	0.00134	CcSEcCtD
Enzalutamide—Headache—Doxorubicin—sarcoma	0.000176	0.00127	CcSEcCtD
Enzalutamide—ABCB1—testis—sarcoma	0.000166	0.00521	CbGeAlD
Enzalutamide—ABCB1—liver—sarcoma	0.000157	0.00492	CbGeAlD
Enzalutamide—ABCB1—lymph node—sarcoma	0.000121	0.00377	CbGeAlD
